Mode
Text Size
Log in / Sign up

Whole-genome sequencing of 108 CRKP isolates from South China reveals ST11 dominance and emerging hvCRKP

Whole-genome sequencing of 108 CRKP isolates from South China reveals ST11 dominance and emerging hv…
Photo by Google DeepMind / Unsplash
Key Takeaway
Recognize emerging ST413-1LV-KL112 hvCRKP carrying blaNDM-1 as a novel threat warranting genomic surveillance in endemic regions.

Investigators conducted a retrospective analysis of 108 CRKP isolates collected from multiple hospitals in South China to describe the molecular epidemiology of antimicrobial resistance and virulence. Whole-genome sequencing combined with Kleborate software was used to profile resistance genes, mutations, and virulence factors, and a phylogenetic tree was constructed to illustrate evolutionary diversification. No comparator cohort was part of the design.

The dominant lineage was ST11, with KL47 the most common capsular serotype and OL101 the most common LPS serotype. KPC-2 was the most prevalent carbapenemase, and KPC-12 — a recently identified and rarely reported KPC-2 variant — was detected in four strains. All ST11 CRKP isolates harbored porin and efflux-pump regulator mutations (AcrR-43%, OmpK35-17%, and OmpK36GD) as reported in the abstract, along with the fluoroquinolone resistance mutations GyrA-83I, GyrA-87G, and ParC-80I. All isolates exhibited complex multidrug-resistant phenotypes.

For virulence determinants, iuc1 was the most common aerobactin type and ybt9 ICEKp3 the most common yersiniabactin type. Seventeen isolates met criteria for hypervirulent CRKP (hvCRKP); these were predominantly ST11-KL64 carrying blaKPC-2 and ST413-1LV-KL112 carrying blaNDM-1, representing a novel hvCRKP type warranting particular attention.

Clinical outcome data, patient-level variables, and treatment responses were not reported, reflecting the microbiological scope of the work. The authors do not quantify temporal trends or enumerate participating hospitals, limiting generalizability beyond the sampled South China setting. Overall findings underscore the convergence of multidrug resistance and hypervirulence in regional CRKP populations and support ongoing genomic surveillance and stringent infection control.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveCarbapenem-resistant Klebsiella pneumoniae (CRKP) has become a worldwide public health concern due to its high morbidity and mortality rate. A retrospective study was conducted to explore the molecular epidemiology of antimicrobial resistance and virulence of CRKP in South China.Methods108 CRKP isolates were collected from multiple hospitals in South China. The characteristics of the CRKP strains, including antimicrobial resistance genes, mutations and virulence factors, were analyzed using whole-genome sequencing and the software Kleborate. A phylogenetic tree was constructed to illustrate evolutionary diversification.ResultsThe main Sequence Type (ST) type, capsular serotype, and LPS serotype among CRKP isolates in South China were ST11, KL47, and OL101, respectively. KPC-2 was the most prevalent carbapenemase type. Notably, KPC-12, a recently identified and rarely reported variant of KPC-2, was discovered in four CRKP strains. All ST11 CRKP isolates harbored porin and efflux pump regulator mutations of AcrR-43%, OmpK35-17%, and OmpK36GD as well as fluoroquinolone mutations of GyrA-83I, GyrA-87G, and ParC-80I. All CRKP strains exhibited complex multi-drug resistance (MDR) phenotypes. The most common types of aerobactin (iuc) and yersiniabactin (ybt) were iuc1 and ybt9 ICEKp3, respectively. There were 17 hvCRKP (hypervirulent carbapenem-resistant Klebsiella pneumoniae) strains found in our study, which were mainly ST11-KL64 and ST413-1LV-KL112, harboring the blaKPC-2 gene and blaNDM-1 gene, respectively.ConclusionIn South China, highly virulent and MDR CRKP strains show a trend toward epidemic, underscoring the urgent need for ongoing genomic surveillance and stringent infection control measures. KPC-2 variant KPC-12 and ST413-1LV-KL112 hvCRKP, a novel type of hvCRKP carrying blaNDM-1, require particular attention and further investigation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.